Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00255099
Status:
COMPLETED
Last Update Posted:
2011-06-15
First Post:
2005-11-15
Brief Title:
TMC125-C216 A Phase III Study to Investigate the Efficacy Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen Including TMC114Ritonavir and an Investigator-selected Optimized Background in HIV-1 Infected Patients With Limited to no Treatment Options
Sponsor:
Tibotec Pharmaceuticals Ireland
Organization:
Tibotec Pharmaceuticals Ireland